Postoperative Analgesia in Bilateral Knee Arthroplasties:Suprainguinal Fascia Iliaca Compartment Block and Local Infiltration Analgesia
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 40
- Locations
- 1
- Primary Endpoint
- Suprainguinal fascia iliaca compartment block (S-FICB) produces adequate analgesic effect in knee arthroplasty.
Study Overview
Brief Summary
To observationally compare the analgesic efficacy of LIA and S-FICB techniques and to record the pain scores of patients who underwent bilateral knee operations in the postoperative period.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to 75 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Planned elective bilateral knee arthroplasty under spinal anesthesia
- •American Society of Anesthesiologists (ASA) risk score I-II
- •Patients aged 18-75 years
Exclusion Criteria
- •Those receiving general anesthesia,
- •Those with epidural catheters,
- •Those who refused to participate in the study,
- •Those whose spinal anesthesia failed and returned to general anesthesia,
- •Those with a body mass index (BMI) >30 kg/m2,
- •History of chronic opioid or corticosteroid use,
- •Patients with psychiatric or neurological problems that would not allow assessment of pain using a visual analog scale (VAS) will be excluded.
- •In addition, patients whose surgery lasted <40 minutes or >120 minutes will also be excluded to keep the data homogeneous.
Outcomes
Primary Outcomes
Suprainguinal fascia iliaca compartment block (S-FICB) produces adequate analgesic effect in knee arthroplasty.
Time Frame: 4 months
The aim of this study was to observationally compare the analgesic efficacy of local infiltration analgesia (LIA) and suprainguinal fascia iliaca compartment block (S-FICB) techniques in patients who underwent bilateral knee operations. Postoperative pain follow-up of the patients will be done by recording Visual analog scales (VAS) at 4, 8, 12 and 24 hours. Additional analgesic needs and unwanted side effects will also be recorded.
Secondary Outcomes
No secondary outcomes reported
Investigators
Merve Yazici Kara
Principal Investigator
Kocaeli City Hospital